Diez-Cirarda, Maria http://orcid.org/0000-0001-6768-189X
Cabrera-Zubizarreta, Alberto
Murueta-Goyena, Ane
Strafella, Antonio P.
Del Pino, Rocio
Acera, Marian
Lucas-Jiménez, Olaia
Ibarretxe-Bilbao, Naroa
Tijero, Beatriz
Gómez-Esteban, Juan Carlos
Gabilondo, Iñigo http://orcid.org/0000-0001-6045-2840
Funding for this research was provided by:
Osasun Saila, Eusko Jaurlaritzako (The Department of Health of the Basque Government through Project 2016111009, The Department of Health of the Basque Government through Project 2016111009, Post-doctoral research improvement fellowship [POS_2018_1_0008])
Article History
Received: 21 July 2022
Revised: 13 October 2022
Accepted: 14 October 2022
First Online: 8 November 2022
Change Date: 6 December 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-022-11492-2
Declarations
:
: A.P.S. has been a consultant for Hoffman La Roche; received honoraria from GE Health Care Canada LTD, Hoffman La Roche. The rest of the authors declare no conflict of interest.
: The present study was approved by the Euskadi Drug Research Ethics Committee (CEIm-E) (Approval number: PI2012154) and participants provided written informed consent prior to research participation.